Aggregator

Amid unprecedented challenges to research and higher education at Harvard University and across the United States this year, Harvard Medical School scientists continued to push the boundaries of biomedical discovery and health care delivery. Get more HMS news Studies conducted at HMS and its affiliated hospitals — often in collaboration with other research institutions and biopharmaceutical companies — deepened understanding of human biology, illuminated mechanisms of common and rare diseases, contributed to development of new treatments and diagnostic tools, and worked to ensure that the best…

The future of federally funded research at Harvard Medical School — supported by taxpayers and done in service to humanity — remains uncertain. Learn more. A new analysis led by researchers at Harvard Medical School’s Blavatnik Institute, Oregon Health & Science University, and Johns Hopkins University provides crucial insight into how the rapid growth in concierge and direct primary care (DPC) practices is transforming the market for primary care in the United States. The researchers found that in just five years, from 2018 to 2023, the number of concierge and DPC practices grew by 83 percent…

Gordon Freeman , Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe , the Kolokotrones University Professor and chair of the Department of Immunology in the Blavatnik Institute at HMS, have been awarded the inaugural Gretener-Thürlemann Prize by the University of Zurich. The prize, worth 500,000 Swiss francs or approximately $625,000, recognizes outstanding researchers in medicine, chemistry and physics for foundational and pioneering research of societal benefit. Get more HMS news here Freeman and Sharpe were honored for decades of discoveries that…

Researchers in the Blavatnik Institute at Harvard Medical School have just opened a new window into understanding the development of antibiotic resistance in bacteria. The work not only reveals principles of evolutionary biology but also suggests a new strategy to combat the antibiotic resistance crisis, which kills an estimated 1.3 million people per year worldwide. Get more HMS news Findings, supported in part by federal funding, are published Nov. 20 in Science. Members of the labs of Michael Baym, associate professor of biomedical informatics, and Johan Paulsson, professor of systems…